RBM4 and esophageal squamous cell carcinoma: Consistent with the in vitro cell culture data, the RBM4-depleted xenograft tumors grew extremely slow compared to control tumors (Fig. 1e, f), indicating that reduction of RBM4 significantly suppresses ESCC progression in vivo.